Filter
801
Text search:
Federal
HIV
Featured
Recommendations
68
New Publications
253
Language
Document type
No document type
508
Studies & Reports
130
Guidelines
74
Manuals
30
Strategic & Response Plan
29
Training Material
14
Fact sheets
6
Situation Updates
5
Brochures
3
Resource Platforms
2
Countries / Regions
Nigeria
121
Ethiopia
117
Nepal
25
Global
24
Brazil
21
Western and Central Europe
19
Latin America and the Carribbean
17
Uganda
16
Germany
13
India
10
Russia
10
South Africa
9
Kenya
8
Eastern Europe
8
South Sudan
7
Bangladesh
7
Africa
7
Zambia
6
Venezuela
6
Liberia
5
Ghana
5
Pakistan
5
Malawi
5
Myanmar / Burma
5
South–East Asia Region
5
Sierra Leone
4
Philippines
4
Tanzania
4
Namibia
4
Asia
4
Haiti
3
Somalia
3
Thailand
3
Indonesia
3
Mozambique
3
Sudan
3
Argentina
3
Ukraine
3
Botswana
3
Mexico
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Guinea
2
Mali
2
Zimbabwe
2
Afghanistan
2
Syria
2
Cambodia
2
Rwanda
2
North Macedonia
2
Colombia
2
Lesotho
2
Yemen
2
East and Southern Africa
2
West and Central Africa
2
North America
2
Burkina Faso
1
Congo, Democratic Republic of
1
USA
1
Togo
1
Jordan
1
Lebanon
1
Turkey
1
China
1
Papua New Guinea
1
Benin
1
Peru
1
Switzerland
1
Honduras
1
El Salvador
1
Bolivia
1
Angola
1
Guatemala
1
Nicaragua
1
Sri Lanka
1
Chile
1
Palestine
1
Canada
1
Tajikistan
1
Qatar
1
Vietnam
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
357
Clinical Guidelines
62
Women & Child Health
37
Public Health
28
Key Resources
26
Capacity Building
7
Pharmacy & Technologies
4
Annual Report MEDBOX
1
Toolboxes
HIV
113
TB
80
COVID-19
49
Mental Health
36
AMR
25
Global Health Education
24
Refugee
23
NTDs
21
Caregiver
19
Rapid Response
18
Disability
14
Health Financing Toolbox
14
Planetary Health
12
Pharmacy
8
Ebola & Marburg
6
Cholera
6
Conflict
6
Polio
4
Zika
4
2.0 Rapid Response
4
Natural Hazards
3
NCDs
2
Malaria
2
Specific Hazards
1
Social Ethics
1
Euro Surveillance 2014;19(47):pii=20970, p.31-37
“Follow the Voice of Life”
AIDSTAR-One | Case study series October 2011
Russian Federation
Accessed: 24.09.2019
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
guidance for health managers, health workers, and activists
PLOS ONE | www.plosone.org 1
December 2013 | Volume 8 | Issue 12 | e82027
The COVID-19 pandemic has exposed the inadequacy of investments in public health, the persistence of profound economic and social inequalities and the fragility of many key global systems and approaches.
Donor government disbursements to combat HIV in low- and middle-income countries totaled US$8 billion in 2018, little changed from the US$8.1 billion total in 2017 and from the levels of a decade ago, finds a new report from the Kaiser Family Founda
...
J HEALTH POPUL NUTR 2010 Aug;28(4):327-332
ISSN 1606-0997
This report provides an analysis of donor government funding to address the HIV response in low- and
middle-income countries in 2022, the latest year available, as well as trends over time. It includes both
bilateral funding from donors and their
...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care.
...
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with
...